Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer

Clinical trial NCT00657904 · COMPLETED

Trial details

NCT number: NCT00657904
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-metastatic Prostate Cancer

Start date: 1995-08-01
Primary completion: 2008-07-01
Enrollment: 3618

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.